deferoxamine (Stanford University School of Medicine)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedeferoxamine (Stanford University School of Medicine)
Drug Alias Namesk-04019deferoxamine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor 1 alpha stimulants
TargetsHypoxia-inducible factor 1 alpha
Therapy Area/IndicationsDiabetic Foot
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesStanford University School of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesStanford University School of Medicine
Inactive CompaniesN/A
Active IndicationsDiabetic Foot
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A